The effect of synthetic polyribonucleotides on EL-4 lymphoma.
D000818:Animals; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D011061:Poly A / Q000627:therapeutic use; D011063:Poly A-U / Q000627:therapeutic use; D011066:Poly C / Q000627:therapeutic use; D011069:Poly I / Q000627:therapeutic use; D011072:Poly U / Q000627:therapeutic use; D011131:Polyribonucleotides / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use; D013997:Time Factors
D011131:Polyribonucleotides; D011063:Poly A-U; D011061:Poly A; D011069:Poly I; D011072:Poly U; D011066:Poly C; D013806:Theophylline